You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Pentostatin

Showing 1 - 25 of 68
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Recurrent Severe Aplastic Anemia, Refractory Severe Aplastic Anemia Trial in Duarte (biological, procedure, drug, other)

Not yet recruiting
  • Recurrent Severe Aplastic Anemia
  • Refractory Severe Aplastic Anemia
  • Anti-Thymocyte Globulin
  • +7 more
  • Duarte, California
    City of Hope Medical Center
Feb 23, 2023

Sickle Cell Disease Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (haploidentical stem cell transplant,

Recruiting
  • Sickle Cell Disease
  • haploidentical stem cell transplant
  • +5 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 18, 2022

Sickle Cell Disease, Thalassemia, Stem Cell Transplantation Trial run by the National Heart, Lung, and Blood Institute (NHLBI)

Recruiting
  • Sickle Cell Disease
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 20, 2023

GVHD Trial in United States (pentostatin)

Completed
Has Results
  • Graft Versus Host Disease
  • pentostatin
  • Lewes, Delaware
  • +15 more
Oct 5, 2021

Acute GVHD Trial in Houston (pentostatin for injection)

Terminated
  • Acute Graft Versus Host Disease
  • pentostatin for injection
  • Houston, Texas
    MD Anderson Cancer Center
Oct 21, 2020

Sickle Cell Disease, Sickle Cell Disorder, Hemoglobinopathies Trial in Duarte (Cyclophosphamide, Pentostatin, Rabbit

Recruiting
  • Sickle Cell Disease
  • +4 more
  • Duarte, California
    City of Hope Medical Center
Jul 6, 2022

GVHD, Immune System Disorders Trial in United States (Etanercept, Mycophenolate Mofetil, Denileukin Diftitox)

Completed
Has Results
  • Graft vs Host Disease
  • Immune System Disorders
  • Duarte, California
  • +18 more
Oct 19, 2021

Follicular Lymphoma, Marginal Zone Lymphoma, Mantle Cell Lymphoma Trial in Shreveport (MTD of Velcade, Nipent and Rituxan

Withdrawn
  • Follicular Lymphoma
  • +2 more
  • MTD of Velcade, Nipent and Rituxan established in Part 1
  • Shreveport, Louisiana
    LSU - Shreveport Health Sciences Center, Feist-Weiller Cancer Ce
Aug 28, 2020

Leukemia, Lymphoma Trial in Scottsdale, Jacksonville, Rochester (Rituximab, Cyclophosphamide, Lenalidomide)

Completed
Has Results
  • Leukemia
  • Lymphoma
  • Rituximab
  • +3 more
  • Scottsdale, Arizona
  • +2 more
Jan 7, 2020

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia Trial in Salt Lake City, Seattle, Torino

Completed
Has Results
  • Acute Lymphoblastic Leukemia
  • +9 more
  • Salt Lake City, Utah
  • +4 more
Jan 15, 2020

Lymphoproliferative Disorders, Autoimmune Lymphoproliferative, Primary T-cell Immunodeficiency Disorders Trial in Bethesda,

Recruiting
  • Lymphoproliferative Disorders
  • +4 more
  • Immunosuppression Only Conditioning
  • +3 more
  • Bethesda, Maryland
  • +1 more
Jan 25, 2023

Mesothelioma, Adenocarcinoma of Lung, Pancreatic Tumors Trial run by the NCI (Pentostatin, Cyclophosphamide, SS1(dsFv)PE38 - lot

Completed
Has Results
  • Mesothelioma
  • +2 more
  • Pentostatin
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 5, 2019

Primary T-cell Immunodeficiency Disorders, Common Variable Immunodeficiency, Immune System Diseases Trial in Bethesda,

Recruiting
  • Primary T-cell Immunodeficiency Disorders
  • +4 more
  • Immunosuppression Only Conditioning -Closed with amendment L
  • +4 more
  • Bethesda, Maryland
  • +1 more
Jul 26, 2022

Amyotrophic Lateral Sclerosis Trial in Boston, Hackensack (RAPA-501 Autologous T cells)

Recruiting
  • Amyotrophic Lateral Sclerosis
  • RAPA-501 Autologous T cells
  • Boston, Massachusetts
  • +1 more
Mar 1, 2022

Leukemia Trial in United States (rituximab, cyclophosphamide, pentostatin)

Completed
Has Results
  • Leukemia
  • rituximab
  • +3 more
  • Scottsdale, Arizona
  • +142 more
Nov 9, 2020

Relapsed, Refractory Multiple Myeloma Trial in Milwaukee (RAPA-201 Autologous T cells)

Recruiting
  • Relapsed, Refractory Multiple Myeloma
  • RAPA-201 Autologous T cells
  • Milwaukee, Wisconsin
    Medical College of Wisconsin
Dec 28, 2021

HIV, Hematologic Malignancies Trial run by the National Cancer Institute (NCI) (RIC, GVHD prophylaxis, allo HCT)

Not yet recruiting
  • HIV
  • Hematologic Malignancies
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 17, 2022

Hairy Cell and Other Leukemias, and to Develop Recombinant

Recruiting
  • Hairy Cell Leukemia (HCL)
  • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Aug 24, 2022

    Leukemia Trial in New York (cyclophosphamide, modified T cells)

    Completed
    • Leukemia
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Jan 9, 2019

    Peripheral T-cell Lymphoma, Cutaneous T-cell Lymphoma, Chronic Lymphocytic Leukemia Trial in Houston (Deoxycoformycin (DCF))

    Completed
    • Peripheral T-cell Lymphoma
    • +2 more
    • Deoxycoformycin (DCF)
    • Houston, Texas
      M. D. Anderson Cancer Center
    Nov 14, 2018

    Myeloid Chimerism Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (CliniMACS CD34 Reagent)

    Recruiting
    • Myeloid Chimerism
    • CliniMACS CD34 Reagent
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Apr 7, 2022

    Recurrent Acute Leukemia of Ambiguous Lineage, Recurrent Acute Lymphoblastic Leukemia, Recurrent Acute Myeloid Leukemia Trial in

    Completed
    Has Results
    • Recurrent Acute Leukemia of Ambiguous Lineage
    • +5 more
    • Chemosensitivity Assay
    • +4 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Jun 29, 2022

    Chronic Lymphocytic Leukemia, Stage 0 Chronic Lymphocytic Leukemia, Stage I Chronic Lymphocytic Leukemia Trial in United States

    Completed
    Has Results
    • Chronic Lymphocytic Leukemia
    • +9 more
    • Scottsdale, Arizona
    • +3 more
    Aug 20, 2018

    Chronic Lymphocytic Leukemia, B-Cell Non-Hodgkin's Lymphoma Trial in Philadelphia (Bendamustine, Pentostatin, Ofatumumab)

    Terminated
    • Chronic Lymphocytic Leukemia
    • B-Cell Non-Hodgkin's Lymphoma
    • Philadelphia, Pennsylvania
      Thomas Jefferson University
    May 23, 2018

    Graft-versus-Host Disease, Immune System Disorders Trial in United States (Mycophenolate Mofetil, Placebo)

    Completed
    Has Results
    • Graft-versus-Host Disease
    • Immune System Disorders
    • Mycophenolate Mofetil
    • Placebo
    • Duarte, California
    • +35 more
    Dec 7, 2022